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Abstract
Background: The inappropriate use of antimicrobials is a problem worldwide. To target future interventions, a
thorough understanding of the reasons behind this current behaviour is needed. Within the EU, the culture of
antimicrobial use has been intensely studied, but this is not the case in non-EU southeastern European countries,
despite the frequent use of (broad-spectrum) antibiotics (ABs) in this region. The aim of this study was to explore
AB knowledge, attitudes and behaviours of health care professionals (HCPs) and patients in one southeastern
European country, Albania.
Methods: In total, 16 semi-structured interviews were carried out with four groups of interviewees: physicians,
community pharmacists, and patients with and without AB prescriptions. Interviews were used to investigate
participants’ recent practices with four specific antibiotics for upper respiratory tract infections, along with their typical
behaviours, knowledge and attitudes towards the use of antimicrobials. A directed content analysis was applied.
Results: The patients showed little awareness of the differences between viruses and bacteria; however, they often
self-diagnosed, which led them to request ABs from pharmacies without a prescription. Pharmacists felt pressured to
give in to patients’ demands. All of the participants (including HCP) showed suboptimal beliefs about illness severity as
they all believed that ‘flu complications’, i.e. flu/cold symptoms that persisted after 2–3 days, should be treated with
ABs. Physicians usually had no rapid tests to guide them in their practice; however, they were not concerned about
this fact. HCPs acknowledged AMR, but only a few of them seemed to consider its risk in their daily practice.
Conclusions: Patients had high levels of trust in and desire for ABs, and HCPs did not often negotiate with patients’
demands. Suggested initiatives to improve the prudent use of ABs in Albania include higher reimbursement for
prescribed antibiotics (to reduce illegal sales), academic detailing as well as implementing public awareness campaigns.
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Background
Antimicrobial agents, such as antibiotics (ABs), have
dramatically reduced the number of deaths from infec-
tious diseases during the 70 years since their introduc-
tion. However, due to the inappropriate use of this type
of medicine, many micro-organisms have become
resistant to antibiotics [1]. This problem is estimated to
cause 25,000 deaths annually in the EU. The costs in-
curred by drug-resistant infections amount to an esti-
mated €1.5 billion annually due to increases in
healthcare expenditures and productivity losses [1].
To combat antimicrobial resistance (AMR), the WHO
Regional Office for Europe has initiated several pro-
grammes for both EU and non-EU member states. One
programme engages in surveillance of drug consumption
in the non-EU countries of southeastern Europe. The
published results from 13 countries in this geographical
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area show some indication of inappropriate AB use. Spe-
cifically, the findings suggest little consumption of
narrow-spectrum penicillin and high consumption of
ABs, such as penicillin combinations, third-generation
cephalosporins and long-acting macrolides, causing an
increased risk of AMR [2].
To support interventions that decrease inappropriate
AB consumption, a qualitative multi-country study was
collaboratively launched in 2014 by non-EU countries in
southeastern Europe, the Health Technology and Phar-
maceuticals group of the WHO, the Regional Office for
Europe and qualitative researchers from the Section of
Social and the Clinical Pharmacy, University of
Copenhagen (SSC) [3]. The aim of the qualitative AMR
study was to explore AB knowledge, attitudes and be-
haviours of health care professionals (HCPs – i.e., both
physicians and community pharmacists) and patients in
each country as a means to target more effective future
interventions in the area.
To date, AB knowledge, attitudes and behaviours are
factors that have been demonstrated to influence the use
of ABs, particularly in western societies. For example, it
has been shown that inappropriate prescribing is driven
by physicians’ perceptions that patients expect AB pre-
scriptions, fear of disease progression and fear of losing
patients to competitors [4–8]. Most HCPs recognize the
risk of AMR; however, they are significantly more likely
to perceive AMR as a national problem rather than one
being affected by their own practice [8, 9]. Contradictory
attitudes towards AB prescribing have also been identi-
fied among non-western physicians [8]. Furthermore,
lack of awareness of appropriate AB use is widespread
among patients. One survey found that on average only
48% of EU residents could correctly state that ABs are
ineffective against the cold and flu, and participants with
low levels of education were more likely to have miscon-
ceptions about ABs [10].
In contrast to most western European countries, many
eastern European countries are prone to the often illegal
sale of over-the-counter (OTC) ABs in community phar-
macies; however, some uncertainty exists about the ac-
tual extent of the problem. A systematic review
published in 2011 found that northeastern European
countries, such as Lithuania, Poland and Romania, have
a high frequency of OTC sales of ABs (approximately
30%), whereas others have suggested that only approxi-
mately 8% of the ABs used in this region are obtained
without a prescription [11]. Furthermore, there are indi-
cations that OTC sales of ABs have in fact decreased in
countries such as Lithuania due to legislation in this area
[12]. The review from 2011 also reported that approxi-
mately 6% of ABs are sold OTC in some countries in
southeastern Europe, i.e., Croatia, Slovenia and Slovakia
[13], while other studies have suggested that
approximately 50% of ABs are sold OTC in this region [2].
This estimate was supported by a study carried out in
Bosnia–Herzegovina in 2010, where 58% of the visited
pharmacies illegally sold ABs without a prescription [14].
One southeastern European country that is a part of
the qualitative WHO AMR research project is Albania.
Albania gained independence in 1912 and is a former
communist country with a distinct culture. Albania has
a GNP of €10.0 billion (2014), which has constrained the
basic education of the public [15], and one-third of its
population (2.8 million inhabitants in total) are not cov-
ered by a public health insurance policy [16]. Only phy-
sicians have the right to prescribe medication and AB
should according to law be obtained by prescription
only. In recent years, Albania has experienced a rapid in-
crease in the number of community pharmacies, which
has challenged the implementation of inspections [17].
The country does not produce or import penicillin V;
additionally, specific guidelines for the use of ABs do
not exist.
Several of these factors are assumed to contribute to
high and inappropriate AB consumption in Albania.
This assumption has partly been demonstrated by stud-
ies showing that illegal OTC sales of ABs occur in 80%
of Albanian pharmacies and that the use of broad-
spectrum and penicillin combinations is common prac-
tice [18, 19].
It has been argued that interventions addressing physi-
cians’ prescribing practices related to ABs must encom-
pass context-specific actions [20]. Thus, to inform
policymakers and other stakeholders of the specific rea-
sons behind the current use of ABs in Albania, the aim
of this study was to investigate the AB knowledge, atti-
tudes and behaviours of patients and HCPs in the
country.
Methods
Qualitative semi-structured interviews were selected as
the most adequate method to investigate AB knowledge,
attitudes and behaviours of patients and HCPs in order
to collect detailed accounts of participants’ individual
experiences and perceptions regarding AB use in order
to understand the culture around this phenomenon in-
depth [21].
Four types of interviewees were included, as they were
all believed to provide valuable insight into the existing
culture of AB use: patients/adults who had used ABs
with a prescription, patients/adults who had used/pur-
chased ABs illegally without a prescription, community
pharmacists (both admitting to legal and non-legal sales
of ABs) and physicians working in the primary care sys-
tem. Despite the fact that physicians and community
pharmacists are the legal and professional gatekeepers to
patients’ access to ABs, the influence of patients on for
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example physicians’ AB prescribing practices has been
demonstrated in previous studies [7, 22]. Therefore, it
was considered important to incorporate these groups in
this study.
The study was restricted to investigate AB use for
upper respiratory tract infections (URTIs) for several
reasons. First, the majority of ABs prescribed in ambula-
tory care are used to treat respiratory tract infections,
and viruses can cause up to 80% of all URTIs [23, 24],
making it an accessible and relevant case for studying in-
appropriate as well as common uses of ABs. Second,
restricting the area of research would allow for more
homogenous data, thereby increasing the possibility of
identifying stronger patterns. Further, four specific ABs
were followed: amoxicillin-clavulanic acid, azithromycin,
ciprofloxacin and ceftriaxone. This decision was made to
ensure the comparability of the data and also because
these specific ABs had been shown to be used inappro-
priately in the region of southeastern Europe, posing a
particular public health risk, as most were broad-
spectrum ABs [2].
Seven general research questions were established in
relation to investigating and addressing AB knowledge,
attitudes and behaviours: the process of diagnosis, how
and why a specific AB was selected, where and how ABs
were purchased, the patients’ use of ABs, satisfaction
with the AB process along with AB knowledge and AB
attitudes. The questions were operationalized as open
questions in interview guides with some variation be-
tween the four groups of interviewees [3]. Hence, phar-
macists for example were only interviewed about
experiences pertaining to his/her pharmacy practice
along with his/her knowledge and attitudes and thus not
interviewed about how diagnosis is carried out by physi-
cians or how patients used the purchased AB (please see
Additional file 1).
In terms of interview technique, to allow for as de-
tailed accounts as possible, patients were asked to an-
swer the different questions specifically in relation to the
most recent occurrence within the last 3 months (to re-
duce memory bias) in which they had one of the four
specific ABs prescribed to them or sold to them at the
pharmacy counter for a URTI. Likewise, HCPs were
asked to describe two or three consultations during the
last week in which they had prescribed or sold a specific
AB for a URTI. Hence, this technique of referring to re-
cent specific incidents was applied to generate coherent
and detailed narratives of interviewees’ experiences with
ABs [25]. For example, a full description of how patients
purchased an AB in a pharmacy without a prescription
would inevitably also contain aspects of the patients’
knowledge and attitudes towards ABs. Additionally, the
narrative would likely include both their and the phar-
macists’ behaviour and social interactions [3]. The
narratives of the different groups of interviewees could
further be compared and used to supplement each other
to achieve a more complete picture of how ABs were
used in daily life. All of the groups were additionally
asked if they had other previous experiences with AB
use, and if so, they were asked whether those instances
were similar to the specific recent account they had just
provided.
The semi-structure of the interviews was thus defined
by a pre-developed interview guide with open questions
to generate narratives and probing during the interviews
according to the achieved answers.
Two interviewers from Albania completed a two-day
training course led by two researchers from an estab-
lished Social Pharmacy research group from the Univer-
sity of Copenhagen. Both of these researchers had
substantial experience with conducting semi-structured
interviews [26]. The training of the Albanian data collec-
tors included how to conduct the semi-structured inter-
views in compliance with the specific requirements of
the qualitative AMR project.
Since the study was considered exploratory, being the
first of its kind in Albania, a convenience yet purposive
sampling strategy was used [27]. Specifically, the snow-
ball sampling technique was used in which the Albanian
researchers asked people in both their professional and
private networks if they knew of patients and HCPs who
fit the inclusion criteria. To reduce selection bias, the re-
searchers attempted to ensure heterogeneity with respect
to age, gender and education.
The participants were verbally informed about the
aim of the project, and all participants provided ver-
bal consent to proceed. The appointments were
agreed upon in advance for two reasons: to ethically
allow participants to withdraw and to ensure that en-
rolled patients had begun their AB treatment before
being interviewed about their medicine use. The in-
terviews were not recorded due to the culture in
Albania in which many people do not feel confident
when recorded. Instead, extensive hand-written notes
were taken. Most of the interviews were thus con-
ducted by both interviewers, allowing one interviewer
to concentrate on taking notes. Two patient inter-
views revealed that the recent use of ABs was for a
URTI affecting the child of the interviewee and not
themselves; these interviews were still included, as
they were considered to be useful for addressing the
study’s research questions.
To ensure feasibility as well as research quality, 16
semi-structured interviews in total were conducted and
included in the analysis (four within each interviewee
group). Kvale recommends 15 interviews plus/minus 10
interviews when conducting semi-structured interviews
in to order to produce validated results [21].
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Analysis
The first step of the analysis involved directed content
analyses [28], in which answers from each of the tran-
scripts/notes pertaining to the general research ques-
tions were extracted, i.e., relevant answers were
deductively identified. In the second step, one partici-
pant’s answers were compared with those from other
participants within the same group to derive a general
understanding of how that group used or thought about
ABs. In the third step, the understanding of each inter-
viewee group was compared with the other groups both
with regard to knowledge, attitudes and behaviour.
Hence, to arrive at a more complete picture of typical
AB behaviour, attitudes and knowledge, the developed
understanding of each group of interviewees was com-
pared and contrasted with other groups. The identified
patterns were then (re-)organized into the initial cat-
egories of knowledge, attitudes and behaviour.
Researchers from Albania and a researcher (first au-
thor) from the SSC carried out the first step separately,
compared their results in a consensus meeting, and then
finalized the last steps of the analysis together. This pro-
cedure was considered to be optimal for ensuring high
validity since the Albanian researchers could identify
certain cultural aspects of AB use, whereas the SSC re-
searchers coming from other cultures could identify
other aspects.
Results
The 16 interviews were conducted between the winter
of 2014 and the spring of 2015. The overall demograph-
ics of the participants are shown in Table 1. Of the 16
participants, 12 were females with patients aged 30 to 59
years (including two mothers of three children between
2 and 6 years of age). The HCPs ranged in age from 27
to 45 years.
Knowledge
The patients expressed their belief that ABs fight infection,
yet most were unsure exactly how they do so. Only a few
patients distinguished between bacterial and viral infections.
The pharmacists stated that ABs should not be used
when OTC medicines such as paracetamol and syrups
were sufficient. Otherwise, with the exception of one
pharmacist who said that ABs should not be used for
viral symptoms, the pharmacists provided no clear re-
sponses regarding AB recommendations. With regard to
the physicians, the majority described how ABs should
be used to treat complicated bacterial or viral infections.
Most of the HCPs acknowledged that AB resistance
exists, and several had observed some situations where
patients returned due to a lack of AB efficiency. How-
ever, at the same time, some HCPs appeared to question
the seriousness of AB resistance. With the exception of
one HCP, the HCPs did not specify any actions in their
daily professional practice in which they took this know-
ledge into consideration.
As no national clinical guidelines on ABs exist in
Albania, the HCPs stated that their basis for AB know-
ledge and AB-related practices came from continuing
educational activities, such as materials on the internet,
visits from pharmaceutical company representatives, dis-
cussions with colleagues, and their formal education.
Attitudes
A common understanding between all interviewee
groups existed that if a patient suffered from flu/cold
Table 1 Participant demographics
Patients with prescription
Age Gender Education/work
30 Male Secondary education
Mother of boy of 6 years
of age
Female Higher education
Mother of children of 2
and 4 years of age
Female Higher education
41 Female Secondary education
Patients without prescription
Age Gender Education/work
36 Female Higher education
28 Female Post graduate education
47 Female Higher education
59 Male Secondary education
Community pharmacists
Age/experience Gender Location of
practice
Size of practice
30–7 years of experience Female Urban area 70–100
customers per
day
27–4 years of experience Female Urban area 100–150
customers per
day
29–6 years of experience Male Urban area 40–60 customers
per day
31–8 years of experience Female Urban area 50 customers
per day
Physicians
Age/experience Gender Location of
practice
Number of
consultations
36–9 years of experience Female Urban area 10–20 patients
per day
45–20 years of experience Male Urban area 15–30 patients
per day
28–4 years of experience Female Rural area 10 patients per
day
42–15 years of experience Female Urban area 20–25 patients
per day
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symptoms for 2–3 days and OTC medicines had not
cured the symptoms within this period, then patients
needed stronger medication to recover, i.e., ABs. Most of
the interviewees described a condition that they referred
to as ‘flu complications’.
The patients and HCPs both seemed to have a high
level of trust in ABs, particularly amoxicillin-clavulanic
acid and azithromycin. The patients appeared to believe
that their symptoms could always be cured. In addition,
the physicians and pharmacists described the need to
give guarantees to patients that the medicines would
work and the blame patients placed on HCPs if their
conditions were not cured.
A pressure to satisfy patients was thus felt by both
physicians and pharmacists. If patients were not satis-
fied, then they threatened to choose another pharmacy
or physician whom they believed could better help them.
Both groups of HCPs admitted that this could lead to
professional practices that were not always optimal. The
pharmacists especially expressed feeling pressured by pa-
tients to sell ABs OTC as if they refused patient would
then turn to another pharmacy. Hence, situations in
which patients requested specific ABs without prescrip-
tions were common. However, the physicians did not ex-
press receiving pressure to prescribe ABs in this way
because if patients truly wanted ABs, then they would
obtain them directly from the pharmacy.
Behaviour
In addition to the concept of treating ‘flu complications’
with ABs, both the patients and HCPs also described
several situations in which ABs were prescribed or sold
to prevent further worsening of flu or cold symptoms,
e.g., patients who were busy at work.
As described, many patients turned directly to phar-
macies to obtain ABs without a prescription. For most
interviewees, including physicians, this type of practice
seemed to be an accepted behaviour. The patients
turned directly to pharmacies for multiple reasons; for
example, their symptoms were perceived to be manage-
able. In these situations, some patients would request a
specific AB with which they had previous positive expe-
riences, or they would request a general AB. A pattern
of self-diagnosis was thus identified. Patients mainly
sought physicians when they had severe symptoms,
symptoms that they had not previously experienced or if
the situation concerned their children.
In situations where patients requested a general AB,
the pharmacists would inquire about the patients’ former
experiences with ABs when deciding what action to take.
To ensure the effectiveness of the AB, several pharma-
cists often selected broad-spectrum ABs.
Regarding physician practices, it was observed that
diagnostic tests were usually not available at public
clinics. The physicians also described that the test results
often took several days to receive. Therefore, physicians
instead relied on their clinical observations, which they
believed to be sufficient in most cases, to make a proper
diagnosis. Several physicians, however, expressed that
they would like to use rapid tests.
It also seemed to be common practice for physicians
to ask patients if they could afford to pay beyond the
public reimbursement scheme, which would allow physi-
cians to prescribe a wider range of ABs – including
some injectable broad-spectrum ABs.
Discussion
Several factors were identified that arguably could lead
to an increased risk of AMR. The patients showed little
awareness of the differences between viruses and bac-
teria; however, they often self-diagnosed, which led them
to request ABs from pharmacies without a prescription.
Especially community pharmacists felt pressured to give
in to patients’ demands. Pharmacists often chose broad-
spectrum ABs to ensure the treatment’s effectiveness.
All of the participants (including HCP) showed incorrect
beliefs about illness severity as they all appeared to be-
lieve that ‘flu complications’, i.e. flu/cold symptoms that
persisted after 2–3 days, should be treated with ABs
even preventatively. Physicians’ attitudes and practices
were also found problematic. Hence, physicians usually
had no rapid tests to guide them in their practice; how-
ever, they were not concerned about this fact. Further,
HCPs acknowledged AMR, but only a few of them
seemed to consider its risk in their daily practice.
Limitations
A relatively small number of people were interviewed
within each interviewee group with regard to the typical
AB culture thereby challenging the validity of the results.
However, due to the specific design of the study, com-
parisons between the four groups’ were applied. These
comparisons allowed researchers to identify relatively
consistent patterns across the groups, and hence only
consistent patterns are reported in this paper.
As qualitative research in general, this study points to
issues of relevance to the investigated topic and we can
therefore not draw conclusions as to whether the results
are transferable to all patients and HCPs in the country
including the frequency and extent of the observed ten-
dencies. Several of our results have been confirmed by
quantitative studies in the country, including the results
related to the common practice of selling ABs without a
prescription in community pharmacies in Albania and
the practice of buying ABs outside the national reim-
bursement scheme, which underlines the argument that
relevant aspects to AB use culture have been identified
in this study [18, 19].
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The results might be biased as most interviews were
conducted in cities, and rural AB practices might differ
from these patterns. Additionally, as the participants
were recruited through snowballing sampling; some par-
ticipants were remotely acquainted with the researchers,
why they may have exhibited more rational AB behav-
iour or having higher knowledge about ABs than the
general population of patients and HCPs. However, all of
the interviewed pharmacists admitted to illegally selling
ABs (perhaps due to not recording the interviews),
which showed that this type of behaviour was also cap-
tured in the sample. The snowball sampling strategy fur-
ther proved suboptimal since it led to the recruitment of
a few patients who did not fit all of the initial inclusion
criteria. The challenges of not recording the interviews
were the loss of details and a generally higher risk of
misinterpreted results due to only having (selective)
notes.
Despite these limits, the specific aim of using qualita-
tive methods to explore AB knowledge attitudes and be-
haviours appears to have been achieved, as several
patterns potentially leading to irrational use of AB were
identified.
Reasons behind inappropriate behaviour
The patients often self-diagnosed, and thus the practice
of purchasing ABs without a prescription was common.
Physicians and especially pharmacists gave in to patient
demands despite not always being comfortable doing so.
This was a very unfortunate finding since HCPs are the
final gatekeepers to the prudent use of ABs.
According to recent literature, pharmacists sell AB il-
legally OTC (although recognising that this is against
the standards set by regulatory authorities) for three
overall reasons: commercial interests, feeling pity for/
wanting to help the patient or finding it counterproduct-
ive to resist patient demand for AB as they could easily
then obtain the AB in another pharmacy [29–31]. Phar-
macists in Albania seem in particular influenced by the
latter i.e. to think that refusing patient to have AB OTC
will have no effect why they eventually gave in and sold
ABs.
In this study, one of the reasons for patients’ strong
desire for ABs (and therefore pressure on pharmacists to
dispense) was the belief that ABs could relieve them of
bothersome symptoms. This high level of patient trust in
ABs has likewise been reported in other countries, and a
study conducted in Russia and Lithuania found that pre-
scribing ABs for URTI has become an integral and even
common practice for these types of infections [6].
Another strong ‘belief precursor’ found in this study
for high AB consumption in Albania was the widely rec-
ognized however overestimated condition of ‘flu compli-
cations’ in terms of severity and need of AB treatment.
Although western physicians also justify prescribing ABs
according to symptom severity and duration, ABs were
prescribed for ‘flu complications’ of shorter durations
and for less serious symptoms than, for example, condi-
tions called ‘toxic’ by British physicians [32]. Patients in
western countries have likewise been demonstrated to
endure symptoms of RTI for more than 2–3 days before
seeking the help of a health care professional [33].
Prescribing ABs as a preventive measure was also ob-
served in this study. This practice has also been reported
in the West but likely to a lesser degree and mostly in
specific situations. For example, a German study showed
a 23% increase in the prescription of ABs on Fridays
[34]. This finding was confirmed by a Norwegian study
in which physicians tended to prescribe more ABs right
before the weekend to help their patients avoid queues
at emergency departments over the weekend [35].
The specific Albanian case
The differences in Albanian HCPs’ quick decisions to
prescribe and sell broad-spectrum ABs might be ex-
plained by this study’s findings showing that HCPs
shared patients’ high level of trust particularly in broad-
spectrum ABs and the common idea of ‘flu complica-
tions’. This was supported by the results, which showed
that some of the HCPs lacked pharmacological know-
ledge about ABs. Hence, physicians in other countries
appear to disagree more often with their patients when
prescribing ABs, and they then try to negotiate with pa-
tients to find a solution, than what was observed in this
study [22].
Another reason for irrational prescribing or dispensing
of broad-spectrum AB might pertain to diagnostic un-
certainty, which was reported by Albanian pharmacists
and likewise reported by physicians in western countries
[4]. Whereas many physicians in western countries re-
port relying on delayed prescribing, adhering to guide-
lines or use a variety of clinical tests as a way to reduce
uncertainty [8, 35–37], Albanian pharmacists often
choose broad-spectrum ABs as a strategy to reduce un-
certainty, i.e., playing it safe. In contrast, Albanian physi-
cians expressed very little diagnostic uncertainty despite
the lack of rapid tests, which is an attitude that has also
been shown among physicians from other non-western
countries [8].
In Sweden it was found that physicians, who used less
structured approaches to diagnose the cause of sore
throat, were more concerned about differential diagno-
ses to and complications of the observed condition com-
pared for example to physicians strictly adhering to
guidelines or using clinical tests in a structure manner
[36, 37]. If this understanding is general and also per-
tains to Albanian physicians using unstructured diagnos-
tic approaches, it could explain why Albanian physicians
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find it necessary often to prescribe AB in these situations
which then leads to irrational prescribing.
To target AB behaviours linked to insufficient know-
ledge and inappropriate attitudes, the underlying culture
and social infrastructure have to be taken into account.
In Albania, this could include paying attention to the
current lack of access to primary care services, as 1/3 of
the Albanian population are not entitled to free medical
consultations. Reimbursing all or most of the price of
regular AB prescriptions could be considered, because at
the current time, reimbursements for ABs with a pre-
scription reduce the total price only by approximately
12%, giving patients little financial incentive to seek a
prescription from a physician. However, physicians in
Lithuania have now suggested the opposite i.e. no reim-
bursement for ABs at all, as they believe reimbursement
leads to higher consumption [12]. Hence, using reim-
bursement as a regulatory mean to control use of ABs
can be challenging.
Other initiatives might include launching public cam-
paigns to raise the public’s awareness about taking ABs
in ‘special’ cases, as this has proven successful in other
countries [8]. A restructuring of the microbial test sys-
tem could also be introduced to provide results to physi-
cians earlier [7, 38], although not all of the physicians in
this study seemed to believe that rapid tests were neces-
sary. Academic detailing helping physicians to reflect on
their own practices could promote an adjustment to this
attitude [7, 8], especially as continuing medical educa-
tion activities are lacking. Currently in Albania, while a
continuing education (CE) system for physicians, den-
tists and pharmacists exists, it is not well structured, and
the responsibility falls on the HCP to seek annual credits
on CE activities and select the type and field of CE activ-
ity in which to participate. Hence, the CE system in
Albania is not prioritizing what are the professional
needs that HPs have to fulfil. Finally, it is essential that
laws regarding the prescribing and dispensing of ABs,
are enforced.
Conclusions
A multitude of reasons for the inappropriate use of anti-
biotics in Albania was identified. Patients’ exhibited high
level of trust in ABs and subsequently requested AB pre-
scriptions or illegally purchasing them over-the-counter,
even for flu-like symptoms lasting for 2–3 days. Health
care professionals did not appear to negotiate with pa-
tients’ demands; pharmacists preferred to play it safe
using broad-spectrum antibiotics, and physicians were
overly confident in their ability to diagnose infections
without rapid tests. Especially pharmacists were found
to give in to selling antibiotics because they did not be-
lieve that they could change the current system.
Suggested initiatives in the future include introducing
higher reimbursement for prescribed antibiotics, aca-
demic detailing to avoid misunderstanding of proper
antibiotic use and public awareness campaigns.
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